Cargando…
The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial
OBJECTIVE: Diabetes mellitus is defined as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both or insulin resistance. Curcumin inhibits NF-κB signaling pathway. The aim of this study is evaluation of the effect of Nano-cur...
Autores principales: | Rahimi, Hamid Reza, Mohammadpour, Amir Hooshang, Dastani, Mostafa, Jaafari, Mahmoud Reza, Abnous, Khalil, Ghayour Mobarhan, Majid, Kazemi Oskuee, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052420/ https://www.ncbi.nlm.nih.gov/pubmed/27761427 |
Ejemplares similares
-
Novel delivery system for natural products: Nano-curcumin formulations
por: Rahimi, Hamid Reza, et al.
Publicado: (2016) -
The effects of nanomicelle of curcumin on the matrix metalloproteinase (MMP-2, 9) activity and expression in patients with coronary artery disease (CAD): A randomized controlled clinical trial
por: Mogharrabi, Marzieh, et al.
Publicado: (2020) -
The effects of curcumin on the prevention of atrial and ventricular arrhythmias and heart failure in patients with unstable angina: A randomized clinical trial
por: Dastani, Mostafa, et al.
Publicado: (2019) -
Response to Letter to the Editor: "Evaluate the effects of curcumin on the prevention of atrial and ventricular arrhythmias and heart failure in patients with unstable angina"
por: Dastani, Mostafa, et al.
Publicado: (2020) -
Non-HDL cholesterol and long-term follow-up outcomes in patients with metabolic syndrome
por: Vazirian, Fatemeh, et al.
Publicado: (2023)